Cargando…
Hypertension in Pediatric Acute Lymphoblastic Leukemia Patients: Prevalence, Impact, and Management Strategies
Acute lymphoblastic leukemia (ALL) is the most common cancer diagnosed in children under the age of 18. While modern diagnostic technologies, risk-stratification, and therapy intensification have led to outstanding outcomes for many children with ALL, the side effects and consequences of therapy are...
Autores principales: | Murphy, Lindsey, Maloney, Kelly, Gore, Lia, Blanchette, Eliza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784271/ https://www.ncbi.nlm.nih.gov/pubmed/35082528 http://dx.doi.org/10.2147/IBPC.S242244 |
Ejemplares similares
-
Blinatumomab, a Bi-Specific Anti-CD19/CD3 BiTE(®) Antibody for the Treatment of Acute Lymphoblastic Leukemia: Perspectives and Current Pediatric Applications
por: Hoffman, Lindsey M., et al.
Publicado: (2014) -
Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020) -
Recent advances in the management of pediatric acute lymphoblastic leukemia
por: Starý, Jan, et al.
Publicado: (2016) -
Assessment of the Prevalence of Infections in Pediatric Patients With Acute Lymphoblastic Leukemia
por: Nair, Arun, et al.
Publicado: (2023) -
The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia
por: Lato, Marta Weronika, et al.
Publicado: (2021)